Literature DB >> 14145222

LUNG ANTIBODIES IN PATIENTS WITH PULMONARY DISEASE.

R G BURRELL, J P WALLACE, C E ANDREWS.   

Abstract

Entities:  

Keywords:  ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; AUTOANTIBODIES; COMPLEMENT FIXATION TESTS; IMMUNE SERUMS; IMMUNOLOGY; LUNG; LUNG DISEASES; SERUM GLOBULINS; TUBERCULOSIS, PULMONARY

Mesh：

Substances：

Year:  1964        PMID： 14145222     DOI： 10.1164/arrd.1964.89.5.697

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  9 in total

1.  Immunopathology of the lung: a review.

Authors:  K J Johnson; W E Chapman; P A Ward
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

2.  Induction of fibrogenesis by lung antibody-treated macrophages.

Authors:  D M Lewis; R Burrell
Journal:  Br J Ind Med       Date:  1976-02

Review 3.  A perspective view on widespread pulmonary fibrosis.

Authors:  M Turner-Warwick
Journal:  Br Med J       Date:  1974-05-18

4.  [Demonstration of tissue antibodies in various lung diseases].

Authors:  C Steffen; F Mlczoch; W Knapp; E Schnetz
Journal:  Klin Wochenschr       Date:  1972-12-15

5.  Immunology and asbestosis.

Authors:  M Turner-Warwick
Journal:  Proc R Soc Med       Date:  1973-09

6.  Lung-reactive antibodies in IgA fractions of sera from patients with pneumoconiosis.

Authors:  J E Hagadorn; R Burrell
Journal:  Clin Exp Immunol       Date:  1968-03       Impact factor: 4.330

7.  [Investigations on the serologic activity of immunoglobulins of bronchial mucus in chronic obstructive airway diseases (author's transl)].

Authors:  S Szabó; B Rasche; E Módy
Journal:  Pneumonologie       Date:  1973-10-31

8.  Trachea-specific antigens in normal and malignant human tissues.

Authors:  N R Rose; H S Bonstein
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

9.  The effect of lung reactive antibodies on the pathogenesis of tuberculosis.

Authors:  R Burrell; C C Cate
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.